{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:03:20Z","timestamp":1793120600359,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.fct.2026.116180","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:37:12Z","timestamp":1779838632000},"page":"116180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Analyzing differences in gut microbiota in secondary failure of sulfonylureas through 16S rDNA sequencing and metabolomics"],"prefix":"10.1016","volume":"215","author":[{"given":"Qingxian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqiong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2026.116180_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1492284","article-title":"Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites","volume":"15","author":"\u0110ani\u0107","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.fct.2026.116180_bib1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.chom.2024.07.017","article-title":"The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes","volume":"32","author":"Baars","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.fct.2026.116180_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077097","article-title":"Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data","volume":"385","author":"Bidulka","year":"2024","journal-title":"Br. Med. J."},{"issue":"OCE3","key":"10.1016\/j.fct.2026.116180_bib3","doi-asserted-by":"crossref","DOI":"10.1017\/S002966512100238X","article-title":"Examining the influence of DPP4 inhibitors and sulphonyureas in combination with metformin on the type II diabetes gut microbiome: a pilot study","volume":"80","author":"Cronin","year":"2021","journal-title":"Proc. Nutr. Soc."},{"issue":"35","key":"10.1016\/j.fct.2026.116180_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400385121","article-title":"The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR\/TSC2\/mTORC1 axis","volume":"121","author":"Du","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"17","key":"10.1016\/j.fct.2026.116180_bib6","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of Type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.fct.2026.116180_bib7","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","article-title":"Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment","volume":"8","author":"Gu","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.fct.2026.116180_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cmet.2017.08.022","article-title":"Meds modify microbiome, mediating their effects","volume":"26","author":"Koropatkin","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.fct.2026.116180_bib10","article-title":"Gut microbiota and antidiabetic drugs: perspectives of personalized treatment in type 2 diabetes mellitus","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.fct.2026.116180_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2217\/pgs-2019-0171","article-title":"Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study","volume":"21","author":"Loganadan","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.fct.2026.116180_bib14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the Most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.fct.2026.116180_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.hoc.2022.03.001","article-title":"The gut microbiome in colorectal cancer","volume":"36","author":"Piawah","year":"2022","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.fct.2026.116180_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.179","article-title":"Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs","volume":"3","author":"Ren","year":"2024","journal-title":"iMeta"},{"issue":"1","key":"10.1016\/j.fct.2026.116180_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.15605\/jafes.037.01.13","article-title":"Review of literature on Akkermansia muciniphila and its possible role in the etiopathogenesis and therapy of type 2 diabetes mellitus","volume":"37","author":"Sanjiwani","year":"2022","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"1","key":"10.1016\/j.fct.2026.116180_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70003","article-title":"Type 2 diabetes mellitus: a comprehensive review of pathophysiology, comorbidities, and emerging therapies","volume":"15","author":"Singh","year":"2025","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.fct.2026.116180_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41574-023-00815-6","article-title":"Sulfonylurea secondary failure mechanism identified","volume":"19","author":"Tysoe","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"681","key":"10.1016\/j.fct.2026.116180_bib24","doi-asserted-by":"crossref","first-page":"eabq4126","DOI":"10.1126\/scitranslmed.abq4126","article-title":"Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes","volume":"15","author":"Watanabe","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.fct.2026.116180_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.fct.2026.116180_bib26","article-title":"Comprehensive analysis of the relationships between the gut microbiota and fecal metabolome in individuals with primary Sjogren's syndrome by 16S rRNA sequencing and LC-MS-Based metabolomics","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.fct.2026.116180_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2375555","article-title":"Akkermansia muciniphila: a promising probiotic against inflammation and metabolic disorders","volume":"15","author":"Zhao","year":"2024","journal-title":"Virulence"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526002541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526002541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:36:37Z","timestamp":1783391797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691526002541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S0278691526002541"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2026.116180","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyzing differences in gut microbiota in secondary failure of sulfonylureas through 16S rDNA sequencing and metabolomics","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2026.116180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116180"}}